
Chih Min Kam
Examiner (ID: 615)
| Most Active Art Unit | 1656 |
| Art Unit(s) | 1656, 1653 |
| Total Applications | 1240 |
| Issued Applications | 817 |
| Pending Applications | 91 |
| Abandoned Applications | 333 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4604747
[patent_doc_number] => 07985727
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2011-07-26
[patent_title] => 'Apo A-I mimetic peptides and methods of treatment'
[patent_app_type] => utility
[patent_app_number] => 11/858851
[patent_app_country] => US
[patent_app_date] => 2007-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 11104
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/985/07985727.pdf
[firstpage_image] =>[orig_patent_app_number] => 11858851
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/858851 | Apo A-I mimetic peptides and methods of treatment | Sep 19, 2007 | Issued |
Array
(
[id] => 4927871
[patent_doc_number] => 20080167234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-10
[patent_title] => 'Use of HMGB fragments as anti-inflammatory agents'
[patent_app_type] => utility
[patent_app_number] => 11/901963
[patent_app_country] => US
[patent_app_date] => 2007-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 21739
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20080167234.pdf
[firstpage_image] =>[orig_patent_app_number] => 11901963
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/901963 | Use of HMGB fragments as anti-inflammatory agents | Sep 18, 2007 | Issued |
Array
(
[id] => 74270
[patent_doc_number] => 07749959
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-07-06
[patent_title] => 'Use of HMGB fragments as anti-inflammatory agents'
[patent_app_type] => utility
[patent_app_number] => 11/901880
[patent_app_country] => US
[patent_app_date] => 2007-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 63
[patent_no_of_words] => 21704
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/749/07749959.pdf
[firstpage_image] =>[orig_patent_app_number] => 11901880
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/901880 | Use of HMGB fragments as anti-inflammatory agents | Sep 18, 2007 | Issued |
Array
(
[id] => 167281
[patent_doc_number] => 07666435
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-23
[patent_title] => 'Treatment of fine wrinkles with clostridia neurotoxins'
[patent_app_type] => utility
[patent_app_number] => 11/852414
[patent_app_country] => US
[patent_app_date] => 2007-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6107
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/666/07666435.pdf
[firstpage_image] =>[orig_patent_app_number] => 11852414
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/852414 | Treatment of fine wrinkles with clostridia neurotoxins | Sep 9, 2007 | Issued |
Array
(
[id] => 4565484
[patent_doc_number] => 07846895
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-12-07
[patent_title] => 'Selectively targeted antimicrobial peptides and the use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/851372
[patent_app_country] => US
[patent_app_date] => 2007-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 21113
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/846/07846895.pdf
[firstpage_image] =>[orig_patent_app_number] => 11851372
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/851372 | Selectively targeted antimicrobial peptides and the use thereof | Sep 5, 2007 | Issued |
Array
(
[id] => 4873200
[patent_doc_number] => 20080199934
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-21
[patent_title] => 'Functional peptide fiber, production method thereof and method for recovering peptide chains'
[patent_app_type] => utility
[patent_app_number] => 11/896711
[patent_app_country] => US
[patent_app_date] => 2007-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7828
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0199/20080199934.pdf
[firstpage_image] =>[orig_patent_app_number] => 11896711
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/896711 | Functional peptide fiber, production thereof and method for recovering peptide chains | Sep 4, 2007 | Issued |
Array
(
[id] => 4772644
[patent_doc_number] => 20080058303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-06
[patent_title] => 'Use of melagatran'
[patent_app_type] => utility
[patent_app_number] => 11/896035
[patent_app_country] => US
[patent_app_date] => 2007-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2385
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20080058303.pdf
[firstpage_image] =>[orig_patent_app_number] => 11896035
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/896035 | Use of melagatran | Aug 28, 2007 | Abandoned |
Array
(
[id] => 4652117
[patent_doc_number] => 20080039373
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-14
[patent_title] => 'Pegylated Factor VII Glycoforms'
[patent_app_type] => utility
[patent_app_number] => 11/845175
[patent_app_country] => US
[patent_app_date] => 2007-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 17212
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20080039373.pdf
[firstpage_image] =>[orig_patent_app_number] => 11845175
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/845175 | Pegylated Factor VII Glycoforms | Aug 26, 2007 | Abandoned |
Array
(
[id] => 4753151
[patent_doc_number] => 20080161226
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-03
[patent_title] => 'Activatable Clostridial Toxins'
[patent_app_type] => utility
[patent_app_number] => 11/845167
[patent_app_country] => US
[patent_app_date] => 2007-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 77965
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0161/20080161226.pdf
[firstpage_image] =>[orig_patent_app_number] => 11845167
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/845167 | Activatable clostridial toxins | Aug 26, 2007 | Issued |
Array
(
[id] => 4698828
[patent_doc_number] => 20080221012
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-11
[patent_title] => 'Activatable Clostridial Toxins'
[patent_app_type] => utility
[patent_app_number] => 11/845252
[patent_app_country] => US
[patent_app_date] => 2007-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 78137
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20080221012.pdf
[firstpage_image] =>[orig_patent_app_number] => 11845252
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/845252 | Activatable clostridial toxins | Aug 26, 2007 | Issued |
Array
(
[id] => 4965739
[patent_doc_number] => 20080108559
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-08
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING DISEASES THROUGH INHIBITION OF DNA METHYLATION AND HISTONE DEACETYLASE'
[patent_app_type] => utility
[patent_app_number] => 11/844290
[patent_app_country] => US
[patent_app_date] => 2007-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11927
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20080108559.pdf
[firstpage_image] =>[orig_patent_app_number] => 11844290
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/844290 | COMPOSITIONS AND METHODS FOR TREATING DISEASES THROUGH INHIBITION OF DNA METHYLATION AND HISTONE DEACETYLASE | Aug 22, 2007 | Abandoned |
Array
(
[id] => 4860261
[patent_doc_number] => 20080269111
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-30
[patent_title] => 'METHOD OF TREATING DYSLIPIDEMIC DISORDER'
[patent_app_type] => utility
[patent_app_number] => 11/843223
[patent_app_country] => US
[patent_app_date] => 2007-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15106
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20080269111.pdf
[firstpage_image] =>[orig_patent_app_number] => 11843223
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/843223 | Method of treating dyslipidemic disorder | Aug 21, 2007 | Issued |
Array
(
[id] => 5509072
[patent_doc_number] => 20090082279
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-26
[patent_title] => 'PEPTIDE ANTAGONISTS OF ZONULIN AND METHODS FOR USE OF THE SAME'
[patent_app_type] => utility
[patent_app_number] => 11/842738
[patent_app_country] => US
[patent_app_date] => 2007-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 10705
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20090082279.pdf
[firstpage_image] =>[orig_patent_app_number] => 11842738
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/842738 | PEPTIDE ANTAGONISTS OF ZONULIN AND METHODS FOR USE OF THE SAME | Aug 20, 2007 | Abandoned |
Array
(
[id] => 5397376
[patent_doc_number] => 20090317439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-24
[patent_title] => 'Cell Preparations for Extemporaneous Use, Useful for Healing and Rejuvenation In Vivo'
[patent_app_type] => utility
[patent_app_number] => 12/438236
[patent_app_country] => US
[patent_app_date] => 2007-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 19110
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0317/20090317439.pdf
[firstpage_image] =>[orig_patent_app_number] => 12438236
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/438236 | Cell preparations for extemporaneous use, useful for healing and rejuvenation in vivo | Aug 20, 2007 | Issued |
Array
(
[id] => 250847
[patent_doc_number] => 07582603
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-09-01
[patent_title] => 'Method for treating or inhibiting intestinal inflammation'
[patent_app_type] => utility
[patent_app_number] => 11/842763
[patent_app_country] => US
[patent_app_date] => 2007-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10756
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/582/07582603.pdf
[firstpage_image] =>[orig_patent_app_number] => 11842763
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/842763 | Method for treating or inhibiting intestinal inflammation | Aug 20, 2007 | Issued |
Array
(
[id] => 6417879
[patent_doc_number] => 20100167328
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-01
[patent_title] => 'BLOOD CELL SEPARATION'
[patent_app_type] => utility
[patent_app_number] => 12/376995
[patent_app_country] => US
[patent_app_date] => 2007-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 8662
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20100167328.pdf
[firstpage_image] =>[orig_patent_app_number] => 12376995
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/376995 | BLOOD CELL SEPARATION | Aug 9, 2007 | Abandoned |
Array
(
[id] => 4734341
[patent_doc_number] => 20080051320
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-28
[patent_title] => 'S-nitrosoprotein preparation and production method therefor'
[patent_app_type] => utility
[patent_app_number] => 11/890542
[patent_app_country] => US
[patent_app_date] => 2007-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 3781
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0051/20080051320.pdf
[firstpage_image] =>[orig_patent_app_number] => 11890542
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/890542 | S-nitrosoprotein preparation and production method therefor | Aug 6, 2007 | Issued |
Array
(
[id] => 5502720
[patent_doc_number] => 20090163408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-25
[patent_title] => 'SALICYLANILIDES ENHANCE ORAL DELIVERY OF THERAPEUTIC PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 11/835338
[patent_app_country] => US
[patent_app_date] => 2007-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 50206
[patent_no_of_claims] => 75
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0163/20090163408.pdf
[firstpage_image] =>[orig_patent_app_number] => 11835338
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/835338 | Salicylanilides enhance oral delivery of therapeutic peptides | Aug 6, 2007 | Issued |
Array
(
[id] => 4688750
[patent_doc_number] => 20080032931
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-07
[patent_title] => 'ACTIVATABLE CLOSTRIDIAL TOXINS'
[patent_app_type] => utility
[patent_app_number] => 11/834068
[patent_app_country] => US
[patent_app_date] => 2007-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 86318
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20080032931.pdf
[firstpage_image] =>[orig_patent_app_number] => 11834068
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/834068 | ACTIVATABLE CLOSTRIDIAL TOXINS | Aug 5, 2007 | Abandoned |
Array
(
[id] => 4688749
[patent_doc_number] => 20080032930
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-07
[patent_title] => 'ACTIVATABLE CLOSTRIDIAL TOXINS'
[patent_app_type] => utility
[patent_app_number] => 11/832173
[patent_app_country] => US
[patent_app_date] => 2007-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 78110
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20080032930.pdf
[firstpage_image] =>[orig_patent_app_number] => 11832173
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/832173 | Activatable clostridial toxins | Jul 31, 2007 | Issued |